Short-Term or Adjunctive Pharmacotherapy With Ongoing SSRI Treatment for Anxiety
Adjunctive medications that are used to target persistent anxiety symptoms while an SSRI (such as sertraline) is continued include buspirone, hydroxyzine, pregabalin, and benzodiazepines for selected short-term use. [1]
Medication Selection Algorithm
Adjunctive or near-term add-on options used with SSRI-based treatment include the following medication classes. [1]
- Buspirone (5-HT1A partial agonist) [1]
- Hydroxyzine (antihistamine anxiolytic) [1]
- Pregabalin (GABAergic anxiolytic) [1]
- Benzodiazepines (short-term anxiolytic) [1]
Key Evidence Supporting This Recommendation
Evidence-supported pharmacotherapy algorithms for generalized anxiety disorder and SSRI-based management describe the following as earlier alternatives or additional options when response is inadequate. [1]
- Buspirone, hydroxyzine, and pregabalin are included among early alternatives to SSRIs. [1]
- Benzodiazepines are included among additional alternatives for inadequate response. [1]
Monotherapy Versus Combination Therapy
When anxiety symptoms persist despite SSRI treatment, algorithm-based management includes either augmentation with another anxiolytic strategy or switching within the SSRI class before moving to other medication classes. [1]
- If SSRI response is inadequate, the next step described in an algorithm is switching to a different SSRI. [1]
- Additional algorithm-described options include adding or transitioning to other anxiolytics such as buspirone, hydroxyzine, pregabalin, or a short-term benzodiazepine strategy. [1]
Important Clarifications or Nuances
An algorithmic approach distinguishes SSRI continuation from subsequent medication changes based on adequacy of response. [1]
- For inadequate response, subsequent steps include trying a different SSRI before escalating to other medication classes. [1]
- For more treatment-resistant patterns, serotonin-norepinephrine reuptake inhibitors and other medication classes are described as later options in the algorithmic sequence. [1]
Initiation Thresholds or Indications
Adjunctive medication selection is driven by inadequate symptom control on an SSRI and the need for faster symptom relief in selected cases. [1]
- Benzodiazepines are described as additional alternatives within the algorithmic options for inadequate response. [1]
Common Pitfalls to Avoid
Key pitfalls are related to sequencing and escalation strategy rather than selecting an adjunct at random. [1]
- Avoiding a structured sequence can delay switching to a different SSRI when the primary SSRI is insufficient. [1]
- Avoiding reassessment of inadequate response can delay escalation to other algorithm-supported medication options. [1]
Treatment Goals
Treatment goals are symptom improvement in generalized anxiety disorder while maintaining SSRI-based therapy, using adjunctive options when symptom response is inadequate. [1]